IN
Inhibitor Therapeutics, Inc.
INTI · OTC
$0.09 +0.00% (+$0.00)
1M -32.92%
Market Cap $10.3M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.06
32.6% downside
Trenutna cena
$0.089
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica INTI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 689.90%
ROA 519.14%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.36x
Debt/Equity N/A
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.70x
EPS volatility 89.29%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INTI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Francis E. O'Donnell Jr.
Employees
8
Headquarters
Tampa